Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
You are in: eMedicine Specialties > Emergency Medicine > Toxicology

Toxicity, Alcohols

Last Updated: January 4, 2007
Email to a Colleague
Synonyms and related keywords: alcohol ingestion, alcohol toxicity, alcohol poisoning, ethanol poisoning, ethanol toxicity, ethanol, methanol poisoning, methanol toxicity, methanol, isopropanol toxicity, isopropanol poisoning, isopropanol, ethyl alcohol toxicity, ethyl alcohol poisoning, ethyl alcohol, methyl alcohol toxicity, methyl alcohol poisoning, methyl alcohol, isopropyl alcohol toxicity, isopropyl alcohol poisoning, isopropyl alcohol, CNS depressant, alcohol metabolism, acute alcohol intoxication

  AUTHOR INFORMATION Section 1 of 10    Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Author: Ann G Egland, MD, Consulting Staff, Department of Operational and Emergency Medicine, Walter Reed Army Medical Center

Coauthor(s): Douglas R Landry, MD, Consulting Staff, Department of Emergency Medicine, Sentara Bayside Hospital

Ann G Egland, MD, is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, Association of Military Surgeons of the US, Medical Society of Virginia, and Society for Academic Emergency Medicine

Editor(s): Jeffrey Glenn Bowman, MD, MS, Consulting Staff, Department of Emergency Medicine, Mercy Springfield Hospital; John T VanDeVoort, PharmD, Clinical Assistant Professor, College of Pharmacy, University of Minnesota; Michael J Burns, MD, Instructor, Department of Emergency Medicine, Harvard University Medical School, Beth Israel Deaconess Medical Center; John Halamka, MD, Chief Information Officer, CareGroup Healthcare System, Assistant Professor of Medicine, Department of Emergency Medicine, Beth Israel Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical School; and Asim Tarabar, MD, Assistant Clinical Professor of Emergency Medicine, Yale University School of Medicine; Consulting Staff, Department of Emergency Medicine, Yale-New Haven Hospital

Disclosure


  INTRODUCTION Section 2 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Background: The 3 most common alcohol poisonings result from ethanol, methanol, and isopropanol (isopropyl alcohol). The devastating and potentially life-threatening toxicity that results from ingestions of any of these alcohols makes recognition of alcohol poisoning an essential part of emergency medicine.

Recognition of the morbidity and mortality that may result from ingestion of small quantities of methanol is particularly important. Ethylene toxicity is covered in a separate article (see Toxicity, Ethylene Glycol).

Pathophysiology: The organs that are most severely affected vary depending on the type of alcohol ingested.

Ethanol

Ethanol (ethyl alcohol) is an aliphatic alcohol present in aftershaves, colognes, perfumes, mouthwashes, over-the-counter (OTC) medications, and a myriad of alcoholic beverages.

Ethanol is a direct CNS depressant, which causes decreased motor function and decreased consciousness level. At high concentrations, ethanol is an anesthetic and can cause autonomic dysfunction (eg, hypothermia, hypotension), coma, and death from respiratory depression and cardiovascular collapse.

Ethanol is easily absorbed from the stomach and small intestine. When the stomach is empty, peak levels are reached 30-90 minutes after acute ingestion. When food is present in the stomach absorption is delayed. Total absorption may take as long as 6 hours.

Metabolism of ethanol is carried out in the liver by several enzymes, including alcohol dehydrogenase, aldehyde dehydrogenase, microsomal ethanol-oxidizing system (MEOS) or CYP2E1, and peroxisomal catalase. Most (90-95%) enzymes are metabolized by alcohol and aldehyde dehydrogenases. MEOS accounts for about 5% but may increase to 25% in the chronic drinker. Normally, catalase makes a small contribution to ethanol metabolism; its role is more significant at high serum ethanol concentrations.

Nonhabituated patients metabolize ethanol at 13-25 mg/dL/h. In persons with alcoholism, this rate increases to 30-50 mg/dL/h. Metabolism rates vary greatly between individuals and cannot be predicted. Similarly, because of tolerance, blood alcohol concentrations (BACs) must be interpreted in conjunction with history and clinical presentation. Some individuals with chronic alcoholism may have an almost normal mental status and neurological examination, yet have BACs of 400 mg/dL. Conversely, nonhabituated drinkers may show marked effects of intoxication at very low BACs.

Methanol

Methanol (methyl alcohol) is found in cleaning materials, solvents, paints, varnishes, Sterno fuel, formaldehyde solutions, antifreeze, gasohol, "moonshine," windshield washer fluid (30-40% methanol), and duplicating fluids.

A CNS depressant, methanol is potentially toxic in amounts as small as a single mouthful. When metabolized by hepatic alcohol and aldehyde dehydrogenase, methanol forms formaldehyde and formic acid, both of which are toxic. The eyes, CNS, and GI tract are affected. Formic acid is the primary toxin that accounts for the majority of the anion gap, metabolic acidosis, and ocular toxicity. Lactic acid also contributes to the anion gap.

Formic acid inhibits cytochrome oxidase in the fundus of the eye. Disruption of the axoplasm is due to impaired mitochondrial function and decreased ATP production. Swelling of axons in the optic disc and edema result in visual impairment. Degradation of formic acid is folate dependent. Thus, if a folate-deficient person ingests ethanol, toxicity may be more severe due to the increased accumulation of formic acid.

Approximately 90-95% of methanol metabolism occurs in the liver, while 5-10% is excreted unchanged through the lungs and kidneys. Methanol is primarily metabolized by alcohol and aldehyde dehydrogenase. Formaldehyde has a short half-life, lasting only minutes. Formic acid is metabolized much more slowly, and it bioaccumulates with significant methanol ingestion.

Isopropanol

Isopropanol is found in OTC rubbing alcohol (70% isopropanol), antifreeze, skin lotions, and some home cleaning products.

Death from ingestion of isopropanol is uncommon. Isopropanol has 2-3 times the potency of ethanol and causes hypotension and CNS and respiratory depression more readily than ethanol. Peak levels occur approximately 30 minutes after ingestion because of rapid GI absorption, which is delayed in the presence of food. Isopropanol is a CNS and cardiac depressant with about twice the potency of ethanol. Serum levels more than 400 mg/dL are potentially fatal.

Approximately 20-50% of isopropanol is excreted unchanged by the kidney, while 50-80% is converted in the liver to acetone, which is a CNS depressant in its own right. Acetone is excreted primarily by the kidneys, with some excretion through the lungs. The elimination half-life of isopropanol is 4-6 hours; that of acetone is 16-20 hours. The prolonged CNS depression seen with isopropanol ingestion is partially related to acetone's CNS depressant effects.

Frequency:

  • In the US: In some studies, alcohol ingestions account for 13-14 hospital admissions per 1000 people. Ethanol is the most common alcohol ingestion. Acute intoxication is seen commonly in the ED. Other studies have shown that up to a third of all patients have detectable ethanol levels at ED presentation, irrespective of the chief complaint. Up to 72% of trauma patients had positive toxicology screen results; ethanol accounted for 55% of these findings.

  • Methanol poisoning epidemics have occurred because of ingestion of contaminated "moonshine." The most notable was in Atlanta in 1951, when 90 gallons of illicit whiskey containing 35-40% methanol produced 323 poisonings and 41 deaths.

  • In 1998, ethanol accounted for 33,269 exposures reported to US poison centers, of which 973 (2.9%) resulted in major toxicity and 42 (0.1%) resulted in death.

  • In 1998, isopropanol accounted for 19,301 exposures reported to US poison centers, of which 83 (0.4%) resulted in major toxicity and 3 (0.02%) resulted in death.

  • In 1998, methanol accounted for 1041 exposures reported to US poison centers, of which 24 (2.3%) resulted in major toxicity and 10 (1%) resulted in death.
  • Internationally: More recently between 2002 and 2004, a total of 51 patients were admitted to the hospital in Norway with methanol poisoning, with 9 in-hospital deaths and 8 out of hospital deaths.

Mortality/Morbidity: Acute intoxication with any of these alcohols may result in coma or death due to respiratory depression and cardiovascular collapse subsequent to CNS depression.

Poor outcomes have been associated with acidosis, hypotension, or coma at presentation.

  • Ethanol, when used chronically, affects multiple organ systems.
  • Methanol ingestion may cause blindness.
  • Isopropanol may cause severe GI hemorrhage, hemolytic anemia, and refractory hypotension.

Age: Alcohols are the most common accidental toxic ingestions by children younger than 5 years. However, because of deliberate ingestions (eg, suicide attempts, recreational use/misuse), toxic ingestions may occur at any age.


  CLINICAL Section 3 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

History: Humans have a long history of ingesting alcohols. Ethanol is the most common deliberate ingestion of this toxic substance. It is a component of a wide variety of beverages that are consumed nearly worldwide.

  • Ethanol
    • Alcoholic beverages are the primary source of ingested ethanol. Other sources include colognes, perfumes, mouthwashes, medications, and aftershave lotions.
    • Ethanol may be ingested accidentally, as often occurs in children, or deliberately, as by the patient with alcoholism or for recreation.
    • Ethanol may be associated with other causes of altered mental status (eg, hypoglycemia, head trauma, mixed ingestions, post-ictal state, carbon dioxide narcosis, hypoxia, infection, hepatic encephalopathy). Consider these conditions when evaluating the patient with known alcohol ingestion.
  • Methanol
    • Methanol ingestion may result in serious consequences, including blindness and death. A delay in treatment may lead to increased morbidity and mortality. Recognition and timely treatment are essential for a full recovery.
    • Methanol commonly is found in numerous compounds, including solvents, photocopy inks and diluents, paints, varnishes, antifreeze, gasoline mixtures (eg, gasohol, "dry gas"), canned heat (eg, Sterno), and even wines (as a byproduct of the natural fermentation process). One study of 11 patients seen between 1995 and 1997 identified 8 patients who had ingested windshield wiper fluid, one who drank gas-line antifreeze, and 2 patients with the source unknown.
    • Toxicity most commonly ensues following accidental or intentional ingestion. Toxicity also may occur following inhalational exposure. Inhalation may be accidental (eg, industrial settings), or it may be deliberate (eg, volatile inhalant abuse, as in "bagging" or "huffing" solvents for their inebriant effects). Transdermal or respiratory tract absorption also may cause toxicity.
    • Following ingestion, methanol is rapidly absorbed from the GI tract. Peak levels occur within 30-90 minutes of ingestion.
    • Methanol is predominantly metabolized in the liver by hepatic alcohol dehydrogenase. At low serum concentrations (<20 mg/dL) and during hemodialysis, methanol elimination is quick and first-order, with an elimination half-life of about 3 hours. At higher serum concentrations, methanol elimination is slow and zero-order, at 8.5 mg/dL/h. Thus, following large doses, methanol is metabolized and eliminated very slowly. Duration of the latent period (time from ingestion until clinical toxicity is evident) is highly variable. Latent periods of 40 minutes to 72 hours have been reported; in most cases, onset of toxicity manifests in 12-24 hours. Co-ingestion of ethanol increases both the latent period (40-50 h) and elimination half-life.
    • Approximately 50% of patients report visual disturbances. These disturbances usually are described as blurry, indistinct, misty, or snowstormlike. Patients also have reported yellow spots, central scotomata, and photophobia.
    • CNS complaints include headache and vertigo. GI complaints may include nausea, vomiting, and abdominal pain due to direct irritation.

    • Complaints do not correlate with the amount or severity of the ingestion.
  • Isopropanol
    • Isopropanol is the second most commonly ingested alcohol. The most common source is rubbing alcohol (70% isopropyl alcohol). Other sources of isopropanol include window cleaners, antifreeze, detergents, jewelry cleaners, solvents, and disinfectants.
    • Ingestions typically occur in alcoholic patients, children, and those who attempt suicide. In children, exposure also may occur from inhalation or topical absorption (eg, sponge bath).
    • CNS complaints include headache, dizziness, poor coordination, and confusion. GI complaints include abdominal pain, nausea, vomiting, and gastritis with hematemesis.
    • Patients appear intoxicated but do not smell like ethanol; however, they may have the fruity odor of acetone.
  • Obtaining a history of the substance and quantity ingested is important. The physician may need to acquire the history from emergency medical services (EMS), parents, relatives, or friends accompanying the patient. Consider other differential diagnoses for altered mental status, as more than a single cause may be present.

Physical: Alcohol ingestions may present in somewhat similar manners. An alteration in mental status is seen with all of the alcohols, given the ingestion of a sufficient quantity of the substance. This alteration may be present to varying degrees depending on the patient.

  • Ethanol
    • Clinical presentation depends on BAC and tolerance to ethanol.
    • The patient may have a flushed face or diaphoresis and may be agitated or ebullient and loquacious due to early disinhibition. This condition may progress to ataxia, slurred speech, drowsiness, stupor, or coma. Nystagmus (horizontal) commonly is observed.
  • Methanol
    • Ocular physical findings include sluggishly reactive or fixed and dilated pupils. Visual field constriction also may be present. Retinal edema or hyperemia of the optic disc may be seen. Optic atrophy may appear in late stages (permanent blindness). Visual symptomology can occur without visible funduscopic changes. Visual acuity often is abnormal.
    • CNS signs include lethargy and confusion. Patients also may present in a comatose condition or with seizures. Cases have been reported of putaminal and cortical necrosis observed on MRI of patients surviving methanol ingestion. Neurologic sequelae (eg, parkinsonism, optic atrophy, focal cranial nerve deficits) have been described.
    • Respiratory signs include dyspnea (rare cases) or even Kussmaul respiration, despite acidosis. Cardiac signs (eg, hypotension, bradycardia) are late signs associated with a poor prognosis.
    • The patient may have severe abdominal tenderness.
    • Death usually is due to abrupt cessation of respiration. Until that endpoint, cardiovascular status is generally well maintained.
  • Isopropanol
    • Nystagmus or miosis may be observed.
    • The patient usually appears intoxicated but smells of acetone instead of ethanol.
    • Sinus tachycardia may be present, but examination usually reveals no other cardiac dysrhythmias.
    • Isopropanol is a GI irritant that causes abdominal pain, nausea, vomiting, and gastritis with hematemesis.
    • Severe ingestions may result in coma, respiratory depression, and hypotension secondary to vasodilatation and negative cardiac inotropy. Loss of deep tendon reflexes (DTRs) also may be observed.
    • In rare cases, myoglobinuria, acute tubular necrosis, hepatic dysfunction, and hemolytic anemia may occur.
  DIFFERENTIALS Section 4 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Alcohol and Substance Abuse Evaluation
Alcoholic Ketoacidosis
Depression and Suicide
Diabetic Ketoacidosis
Encephalitis
Hyperosmolar Hyperglycemic Nonketotic Coma
Hypoglycemia
Meningitis
Pancreatitis
Pediatrics, Diabetic Ketoacidosis
Pediatrics, Hypoglycemia
Pediatrics, Meningitis and Encephalitis
Status Epilepticus
Stroke, Hemorrhagic
Subarachnoid Hemorrhage
Toxicity, Alcohols
Toxicity, Ethylene Glycol
Toxicity, Iron
Toxicity, Isoniazid
Toxicity, Lithium
Toxicity, Mushroom - Amatoxin
Toxicity, Salicylate


Other Problems to be Considered:

Cyanide toxicity

Quick Find
Author Information
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
Bibliography

Click for related images.

Related Articles
Alcohol and Substance Abuse Evaluation

Alcoholic Ketoacidosis

Depression and Suicide

Diabetic Ketoacidosis

Encephalitis

Hyperosmolar Hyperglycemic Nonketotic Coma

Hypoglycemia

Meningitis

Pancreatitis

Pediatrics, Diabetic Ketoacidosis

Pediatrics, Hypoglycemia

Pediatrics, Meningitis and Encephalitis

Status Epilepticus

Stroke, Hemorrhagic

Subarachnoid Hemorrhage

Toxicity, Alcohols

Toxicity, Ethylene Glycol

Toxicity, Iron

Toxicity, Isoniazid

Toxicity, Lithium

Toxicity, Mushroom - Amatoxin

Toxicity, Salicylate


Patient Education
Click here for patient education.



  WORKUP Section 5 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Lab Studies:

  • Finger stick for blood glucose level
    • With ethanol and methanol toxicity, the patient may be hypoglycemic.
    • With isopropanol toxicity, the patient is not hyperglycemic. This distinction helps differentiate alcohol toxicity from diabetic ketoacidosis (DKA).
  • Serum electrolytes, blood urea nitrogen, creatinine, and glucose levels
    • For ethanol and methanol toxicity, look for increased serum osmolal gap accompanied by an increased serum anion gap and hypoglycemia.

    • Isopropanol toxicity also produces an elevated osmolal gap, but generally no abnormal anion gap, although this may be seen as a result of hypotension and lactic acidosis. A spurious increase in serum creatinine as a result of acetone may be seen.
    • Serum formic acid levels are a better indication of toxicity than are methanol levels. Formate concentrations are rarely available and are not accessible in time to guide therapy.
  • Serum amylase or lipase level for detecting any associated pancreatitis

  • Complete blood count
    • Ethanol: Leukocytosis, anemia, or thrombocytopenia may be present. Such findings are more common in the individual with chronic alcoholism.

    • Methanol: Anemia may be present.

    • Isopropanol: Hemolytic anemia may appear in rare instances.
  • Serum osmolality
    • The osmolal gap is calculated by subtracting calculated serum osmolality from the measured serum osmolality (see Procedures for calculation).

    • Ethanol increases osmolal gap by 22 mOsm/L for each 100 mg/dL. Methanol increases the osmolal gap by 32 mOsm/L for every 100 mg/dL. Isopropanol increases the osmolal gap 17 mOsm/L for each 100 mg/dL of isopropanol and by 18 mOsm/L for each 100 mg/dL of blood acetone.

    • While usually helpful in guiding management, the osmolal gap is neither sensitive nor specific for the presence of a toxic alcohol or glycol. The absence of an osmolal gap does not rule out significant toxic alcohol ingestion.
  • Arterial blood gas
    • Methanol: A severe anion gap metabolic acidosis is the hallmark. Severity of acidosis is the best predictor of prognosis when clinical status also is considered.

    • Isopropanol: The patient is not acidotic.
  • Urinalysis
    • Urine may possess an odor of formaldehyde.

    • Ethanol serum concentration: Used for confirmation of ethanol intoxication.
  • Ethanol concentration also is important for methanol ingestions, since it predicts prolongation of toxic levels and of the latent period before onset of symptoms.
    • Ethanol effects at various BAC levels for nonhabituated drinkers are as follows:

      • 20-50 mg/dL – Decreased fine motor function

      • 50-100 mg/dL – Impaired judgment and coordination

      • 100-150 mg/dL – Difficulty with walking and balance

      • 150-250 mg/dL – Lethargy

      • 300 mg/dL – Coma

      • 400 mg/dL – Respiratory depression

      • 500 mg/dL – Potential death
  • Methanol concentration: This study confirms ingestion and helps guide treatment. Remember that low serum concentrations (ie, < 20 mg/dL) do not rule out significant toxicity; late presenters may have low methanol concentrations but elevated formic acid levels and severe clinical toxicity (eg, severe metabolic acidosis, blindness, coma). Methanol concentrations at various BAC levels are as follows:
    • 0-20 mg/dL – Usually asymptomatic

    • 20-50 mg/dL – Treatment required

    • 150+ mg/dL – Potentially fatal if untreated

    • Levels more than 20 mg/dL are considered toxic and are the action level (ie, when treatment should be initiated based on level alone.)
  • Isopropanol concentration: This laboratory study confirms and quantitates alcohol concentration. Clinical presentation is a better indicator of prognosis.
    • Serum ketones may be increased within 30 minutes of ingestion of isopropanol because of acetone production.

    • Acetone is detected in urine 3 hours after ingestion.

Procedures:

  TREATMENT Section 6 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Prehospital Care: Follow established protocols.

  • Obtaining a detailed history of the ingestion or exposure from all available sources is important.
  • Inspect bottles of ingested substances to help identify possible alcohols.
  • Follow standard protocols for treating patients with airway obstruction, unconsciousness, or altered mental status.

Emergency Department Care: Provide airway, breathing, and circulation evaluation and support as necessary. Orogastric lavage with a large-bore (eg, Ewald) tube is not recommended. Standard-size nasogastric (NG) tube insertion, aspiration, and rapid lavage may be beneficial soon after ingestion and may be attempted up to 4 hours following ingestion (ie, food in the stomach may significantly delay alcohol absorption). Activated charcoal does not bind alcohols well but should be administered if a mixed ingestion is suspected. Administer naloxone if opiates are suspected. Administer thiamine (100 mg) and dextrose D50W (25-50 g) IV for the obtunded patient.

  • Ethanol
    • Treatment of acute intoxication involves providing supportive measures (eg, fluid monitoring, oxygen, airway protection).

    • Remember that intoxicated patients are at an increased risk for other traumatic and medical pathologies, which must be ruled out or appropriately treated.
  • Methanol
    • Supportive measures are indicated for patients with methanol ingestion. Monitor fluids and oxygen, and provide airway protection. Forced diuresis is recommended, since methanol is excreted renally; however, dialysis works better and has less danger of pulmonary edema, cerebral edema, or acute respiratory distress syndrome (ARDS).

    • Attempted correction of acidosis using sodium bicarbonate is indicated if pH is less than 7.20; note that patients may require large quantities. An alkalemic pH makes it more likely that formic acid will exist as its anion (formate), which cannot access the CNS and optic nerve as readily.

    • Administer folic acid (leucovorin) 50 mg IV every 4 hours for several days to potentiate the folate-dependent metabolism of formic acid to carbon dioxide and water.
    • Ethanol infusion is recommended for patients with suspected methanol ingestion and/or levels greater than 20 mg/dL. Consider ethanol infusion in any patient with an unexplained osmolar gap and/or elevated anion-gap metabolic acidosis that is unaccounted for by ethanol, until a definitive diagnosis negating its administration is made.

      • Ethanol is a competitive inhibitor of alcohol dehydrogenase and, thereby, impairs the metabolism of methanol and ethylene glycol. Ethanol has 10-20 times greater affinity for alcohol dehydrogenase than methanol does. This measure increases the half-life to approximately 40 hours.

      • Maintain blood ethanol concentrations between 100-150 mg/dL. This level is intoxicating for nonalcoholics; the dosage may need to be increased for chronic drinkers. Ethanol levels must be followed frequently.

      • Ethanol may be given PO or IV. PO administration requires an alert patient and may have variable rates of absorption and wide fluctuations in blood levels. Administration of ethanol also causes gastritis. IV administration provides more constant blood levels, but it may cause thrombophlebitis. Parenteral alcohol is indicated if the patient has evidence of pancreatitis.

      • Begin treatment with a loading dose of 0.6-0.8 g/kg IV or PO. Maintenance levels typically range from 0.8-1.4 g/kg/h. For infusion with 10% ethanol in D5W, loading dose is 10 mL/kg, and maintenance is 1.6 mL/kg/h. Administration of an oral loading dose is possible using commercially available beverages. Dosage may be calculated using the following equation: Ethanol in grams = (mL beverage) X 0.8 X (proof/2).

      • The goal of ethanol administration is to maintain a serum ethanol concentration more than or equal to 100 mg/dL. Maintain this ethanol level until the methanol level is less than 20 mg/dL. Some physicians advocate continuing ethanol infusion until the methanol level reaches zero.
    • Dialysis may be needed to remove methanol and its principal toxic metabolite, formate. Dialysis is 40-50 times faster than renal clearance. Hemodialysis is recommended for intractable/severe acidosis (ie, pH <7.20), renal failure, visual symptoms, or methanol serum concentrations more than 50 mg/dL.

    • Studies have shown that prognosis is not dependent on the blood concentration of methanol but on the degree of metabolic acidosis present. This observation is logical when considering toxins as the cause of the acidosis; worsening acidosis means more toxic metabolites are present. Prognosis probably correlates closely with the plasma formate concentration on presentation (a test not readily available).
  • Isopropanol
    • Treat hypotension with fluids and pressors, if needed. NG suctioning is ineffective, since minimal resecretion to the stomach occurs.
    • Initiate emergent hemodialysis for patients with refractory hypotension or blood levels more than 400 mg/dL.

Consultations:

  • Consultations depend on the substance and severity of the ingestion and as well as the patient's age.
  • Ethanol

    • For acute ethanol intoxication, patients may not need admission. Patients may require monitoring if a concurrent injury or other problem exists.
    • For chronic ethanol abuse, the patient may need admission for ongoing medical problems (eg, liver, GI, hematologic, metabolic, CNS effects). Consider and offer referral for substance abuse treatment.
  • Methanol

    • For acute methanol ingestion, the patient may need admission for dialysis, ethanol or fomepizole therapy.

    • The patient may need monitoring in an ICU setting.
  • Isopropanol

    • For acute isopropanol ingestion, the patient may need admission for treatment of GI bleeding in a monitored setting.

    • The patient also may need treatment for CNS depression in a monitored setting.

  MEDICATION Section 7 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Methanol poisoning only: Alcohol dehydrogenase has greater affinity for ethanol than methanol; therefore, ethanol infusions are used to inhibit methanol breakdown to toxic metabolites (eg, formaldehyde, formic acid).
Fomepizole (eg, 4-methylpyrizole, 4-MP, Antizol) has greater affinity for alcohol dehydrogenase than ethanol or methanol and has a considerably better safety profile than ethanol. Fomepizole recently was approved by the US Food and Drug Administration (FDA) for ethylene glycol poisoning, but it is useful for managing methanol poisoning as well.

Drug Category: Pharmacologic antidotes -- These agents prevent formation of toxic metabolites in methanol ingestions (not useful with isopropanol or ethanol ingestions). Therapy generally is maintained until methanol levels are less than 20 mg/dL.
Drug Name
Ethanol -- Has 10-20 times greater affinity for enzyme alcohol dehydrogenase than methanol does, blocking production of toxic metabolites.
Believed to inhibit ADH when serum levels exceed 0.05 g/dL (50 mg/dL). Titration to serum levels between 0.10 g/dL (100 mg/dL) and 0.15 g/dL (150 mg/dL) typically used.
Measure patient's initial blood level. May be administered PO/IV
Adult DoseIf BAC <100 mg/dL, loading dose may be unnecessary, thus patient can be started on a maintenance dose
IV load: 7.6-10 mL/kg IV of 10% ethanol (V/V) in D5W over 30 min to achieve a blood EtOH concentration of 100-130 mg/dL (21.7-28.2 mmol/L
Oral load: 0.8-1 mL/kg PO of 95% ethanol (V/V) in 6 oz of orange juice over 30 min
Average maintenance doses: 0.15 mL/kg/hr PO of 95% EtOH; 1.4 mL/kg/h IV of a 10% solution
Frequently monitor BAC; adjust dose to reduce methanol levels to <20 mg/dL
Pediatric DoseAdminister as in adults on mL/kg basis; obtain serum BAC 100-150 mg/dL
ContraindicationsExtreme caution if patient has ingested other CNS depressants
Interactions May increase toxicity of benzodiazepines and result in death
Pregnancy C - Safety for use during pregnancy has not been established.
PrecautionsAdministered IV may cause thrombophlebitis; may cause gastritis when administered PO; watch for hypoglycemia, especially in children
Drug Name
Fomepizole (4-MP, Antizol) -- DOC for ethylene glycol and methanol poisoning, due to ease of administration and better safety profile than ethanol. Inhibitor of alcohol dehydrogenase. In contrast to ethanol, 4-MP levels do not require monitoring during therapy.
Begin fomepizole treatment immediately upon suspicion of ethylene glycol ingestion based on patient history or anion gap metabolic acidosis, increased osmolar gap, oxalate crystals in the urine or a documented serum methanol level. Adjust dosing during hemodialysis; see package insert.
Adult DoseLoading dose: 15 mg/kg IV over 30 min
Maintenance doses: 10 mg/kg IV q12h for 4 doses and 15 mg/kg IV q12h thereafter until methanol in the blood has been reduced to safe levels
Pediatric DoseNot established; cautiously administer as in adults
ContraindicationsDocumented hypersensitivity
InteractionsPO fomepizole (10-20 mg/kg) may reduce rate of elimination of ethanol by 40% in healthy volunteers; ethanol may decrease rate of elimination of fomepizole by 50%
Pregnancy C - Safety for use during pregnancy has not been established.
PrecautionsRisk of toxic reactions may be greater in patients with impaired renal function (eg, elderly); do not administer undiluted or by bolus injection as venous irritation and phlebosclerosis may occur; associated with seizures, asymptomatic hepatic transaminitis, eosinophilia, and rash
Drug Name
Folic acid (Folvite) -- Adjunctive agent in methanol ingestion. Member of vitamin B-complex that may enhance elimination of toxic metabolite formic acid produced when methanol is metabolized. Useful in methanol and possibly ethylene glycol toxicity. Leucovorin (folinic acid) is active form of folate and may be substituted for folic acid.
Folic acid should be administered for several days to enhance folate-dependent metabolism of formic acid to carbon dioxide and water.
Adult Dose50 mg IV q4-6h to increase rate of formic acid metabolism; leucovorin can be administered 1-2 mg/kg IV q4-6h
Pediatric DoseSodium folate: 1 mg/kg IV q4-6h
Leucovorin: 1 mg/kg IV q4-6h
ContraindicationsDocumented hypersensitivity
InteractionsIncrease in seizure frequency and a decrease in subtherapeutic levels of phenytoin reported when used concurrently
Pregnancy A - Safe in pregnancy
PrecautionsBenzyl alcohol may be contained in some products as a preservative (associated with a fatal gasping syndrome in premature infants); resistance to treatment may occur in patients with alcoholism and deficiencies of other vitamins
  FOLLOW-UP Section 8 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Further Inpatient Care:

Transfer:

Complications:

  MISCELLANEOUS Section 9 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Medical/Legal Pitfalls:

  • Assuming that ingestion of an alcohol accounts for altered mental status rather than conducting a thorough search for head injuries and other etiologies (eg, trauma, infection, psychogenic causes, seizure/syncope, alcohol, encephalopathy/endocrinopathy/electrolytes, insulin, opiates, uremia [TIPS AEIOU]), especially in patients with profound or prolonged depression in mental status or whose history of present illness is unreliable or unobtainable
  • Treatment of the patient based solely on ethanol concentration rather than including the patient's physical examination
  • Failure to follow serial levels of alcohols (especially methanol)
  • Failure to realize that extremely small amounts of methanol can lead to life-threatening toxicity
  • Failure to institute or delay in instituting ethanol or fomepizole therapy for significant methanol ingestion
  • Failure to consider methanol as a potential toxin because both anion and osmolal gaps are normal (late presentations)
  • Failure to consider ingestion of alcohols as a possible cause of altered mental status, especially in children
  BIBLIOGRAPHY Section 10 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

  • Agency for Toxic Substances and Disease Registry: Methanol toxicity. Am Fam Physician 1993 Jan; 47(1): 163-71[Medline].
  • Anderson I: Methanol. In: Olsen K, et al, eds. Poisoning and Drug Overdose. 3rd ed. Simon & Schuster Trade; 1999:218-20.
  • Aufderheide TP, White SM, Brady WJ, Stueven HA: Inhalational and percutaneous methanol toxicity in two firefighters. Ann Emerg Med 1993 Dec; 22(12): 1916-8[Medline].
  • Berk W, Henderson W: Alcohols. In: Emergency Medicine: A Comprehensive Study Guide. 4th ed. McGraw-Hill; 1996:765-72.
  • Birmbaumer D, Besson H: Alcohols and glycols. In: Emergency Medicine Concepts and Clinical Practice. 3rd ed. Mosby-Year Book; 1992: 2520-32.
  • Brent J, McMartin K, Phillips S, et al: Fomepizole for the treatment of methanol poisoning. N Engl J Med 2001 Feb 8; 344(6): 424-9[Medline].
  • Burgess E: Prolonged hemodialysis in methanol intoxication. Pharmacotherapy 1992; 12(3): 238-9[Medline].
  • Burkhart KK, Kulig KW: The other alcohols. Methanol, ethylene glycol, and isopropanol. Emerg Med Clin North Am 1990 Nov; 8(4): 913-28[Medline].
  • Burns MJ, Graudins A, Aaron CK, et al: Treatment of methanol poisoning with intravenous 4-methylpyrazole. Ann Emerg Med 1997 Dec; 30(6): 829-32[Medline].
  • Clark RF, Harchelroad F: Toxicology screening of the trauma patient: a changing profile. Ann Emerg Med 1991 Feb; 20(2): 151-3[Medline].
  • Corley RA, McMartin KE: Incorporation of therapeutic interventions in physiologically based pharmacokinetic modeling of human clinical case reports of accidental or intentional overdosing with ethylene glycol. Toxicol Sci 2005 May; 85(1): 491-501[Medline].
  • Garella S: Extracorporeal techniques in the treatment of exogenous intoxications [clinical conference]. Kidney Int 1988 Mar; 33(3): 735-54[Medline].
  • Hornfeldt CS: A report of acute ethanol poisoning in a child: Mouthwash vs cologne, perfume and aftershave. J Toxicol Clin Toxicol 1992; 30(1): 115-21[Medline].
  • Hovda KE, Hunderi OH, Tafjord AB, et al: Methanol outbreak in Norway 2002-2004: epidemiology, clinical features and prognostic signs. J Intern Med 2005 Aug; 258(2): 181-90[Medline].
  • Hovda KE, Andersson KS, Urdal P, Jacobsen D: Methanol and formate kinetics during treatment with fomepizole. Clin Toxicol (Phila) 2005; 43(4): 221-7[Medline].
  • Kearney T: Fomepizole (4-MP). In: Olsen K, et al, ed. Poisoning and Drug Overdose. 3rd ed. Simon & Schuster Trade; 1999:370-1.
  • Palatnick W, Redman LW, Sitar DS, Tenenbein M: Methanol half-life during ethanol administration: implications for management of methanol poisoning. Ann Emerg Med 1995 Aug; 26(2): 202-7[Medline].
  • Pappas AA, Ackerman BH, Olsen KM, Taylor EH: Isopropanol ingestion: a report of six episodes with isopropanol and acetone serum concentration time data. J Toxicol Clin Toxicol 1991; 29(1): 11-21[Medline].
  • Vivier PM, Lewander WJ, Martin HF, Linakis JG: Isopropyl alcohol intoxication in a neonate through chronic dermal exposure: a complication of a culturally-based umbilical care practice. Pediatr Emerg Care 1994 Apr; 10(2): 91-3[Medline].
  • Wright R, et al: Poison antidotes: Guidelines for rational use in the emergency department. Emerg Med Rep 1995; 16(21).

Toxicity, Alcohols excerpt